Celldex Therapeutics buy Barclays PLC
Start price
20.04.26
/
50%
€29.16
Target price
20.04.27
€38.28
Performance (%)
-14.78%
Price
08:01
?
Summary
This prediction is currently active. The prediction for Celldex Therapeutics disappoints with a performance of -14.78%. This prediction currently runs until 20.04.27. The prediction end date can be changed by Barclays_PLC at any time. Barclays_PLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | -6.274% | -6.274% |
| iShares Core DAX® | -1.756% | 1.667% |
| iShares Nasdaq 100 | 2.324% | 12.779% |
| iShares Nikkei 225® | 5.022% | 13.300% |
| iShares S&P 500 | 0.802% | 6.198% |
Comments by Barclays_PLC for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) was upgraded by Barclays PLC from "underweight" to "overweight". They now have a $45.00 price target on the stock.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Barclays_PLC for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€28.82
08.05.26
08.05.26
€40.93
08.05.27
08.05.27
-13.78%
08:01
08:01
Celldex Therapeutics
Start price
Target price
Perf. (%)
€21.80
17.12.25
17.12.25
€20.43
17.12.26
17.12.26
16.15%
08:01
08:01
Celldex Therapeutics
Start price
Target price
Perf. (%)
€20.80
11.11.25
11.11.25
€18.18
11.11.26
11.11.26
21.73%
08:01
08:01